Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02442011 · ClinicalTrials.gov registry record
Hematology Biobank: In Vitro Study of Blood Disorders
A clinical trial of Hematological Disorders, sponsored by Albert Einstein College of Medicine.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT02442011: Recruiting study of Hematological Disorders, sponsored by Albert Einstein College of Medicine.
NCT02442011 is a study of Hematological Disorders that is actively recruiting participants, run by Albert Einstein College of Medicine. The registered enrollment target is 2,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02442011, a study of Hematological Disorders, is actively recruiting participants, sponsored by Albert Einstein College of Medicine.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a biorepository of blood specimens from subjects with different Hematological disorders.
Primary Outcome
To have specimens available for IRB approved studies
Conditions Studied
Study Locations (1)
New York
- Montefiore Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2014-01 |
| Est. Completion | 2030-01 |
What NCT02442011 shows while recruiting
NCT02442011 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Hematological Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT02442011 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02442011 about?
NCT02442011 is a clinical study titled "Hematology Biobank: In Vitro Study of Blood Disorders". This is a biorepository of blood specimens from subjects with different Hematological disorders.
What is the current status of trial NCT02442011?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2014-01. Estimated completion is 2030-01.
What conditions does trial NCT02442011 study?
This clinical trial studies the following conditions: Hematological Disorders.
Who is sponsoring clinical trial NCT02442011?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02442011 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia